NCT01706939View on ClinicalTrials.gov

The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

September 1, 2012

Primary Completion Date

April 1, 2020

Study Completion Date

May 1, 2035

Conditions
Squamous Cell Carcinomas
Interventions
RADIATION

Reduced Dose Radiation

Reduced Dose Radiation (5600 cGy) dose radiotherapy

RADIATION

Standard Dose Radiation

Standard Dose Radiation (7000 cGy) dose radiotherapy

DRUG

Carboplatin

Day 1, every 7 days ( + 2 days)

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

Sponsors

Collaborators (1)

Biodesign Institute
All Listed Sponsors
collaborator

Biodesign Institute

OTHER

collaborator

Arizona State University

OTHER

lead

Icahn School of Medicine at Mount Sinai

OTHER